| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0082 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |